Formycon
Martinsried
About Formycon
Formycon GmbH is more than a regular CRO that provides formulation and analytical services to the biopharmaceutical industry. The complete analytical development chain – starting from protein characterization and comparability studies up to GMP Quality Control and stability testing of clinical study and market medication. The Formulation one-stop shop – Formycon covers pre-formulation, development of systemic and local, liquid, freeze-dried and sustained release drug product formulations, supply of pre-clinical studies and development of the manufacturing process.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $172.1M
- Funding stage: IPO
- Last round: Post-IPO Debt (Jun 2025)
- Ticker: fra:FYB
- Website: formycon.com
- Phone: +49 89 864667100
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/formycon-64776 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.